Booth No.6C-05
CategoryIngredients
PavilionChina Pavilion
NANJING CONFIDENCE CHEMICAL CO.,LTD
Booth No.：6C-05
Category：Ingredients
Pavilion：China Pavilion
Company Information
Email：
piers@cfdechem.com
TEL： +86-159-5168-3105
Address： 4#building, Shenglong Huijin Plaza, No. 288 Lushan Road, Jianye District, Nanjing City.,210019 CHINA
URL：
http://cfdechem.com
Contact in Japan
Japan agent： Nanjing Confidence Chemical Co.,Ltd.
Established in 2014, Registered in Nanjing, China, focusing on the field of fine chemical, pharmaceuticals intermeidates and API, etc. Established long-standing cooperation with many foreign customers through production, process study and optimization,R&D, quality control, custom manufacturing, high efficiency logistics and finance support.
Company information
| Address | 4#building, Shenglong Huijin Plaza, No. 288 Lushan Road, Jianye District, Nanjing City.,210019 CHINA |
|---|---|
| TEL | +86-159-5168-3105 |
| URL | http://cfdechem.com |
| piers@cfdechem.com |
| Product Classification |
Dehydroabietylamine，CAS 1446-61-3 Ethyl 4-butylaminobenzoate, CAS 94-32-6 (R)-(-)-Epichlorohydrin，CAS 51594-55-9 (S)-(+)-Epichlorohydrin, CAS 67843-74-7 Allylamine, CAS No.: 107-11-9 Sevelamer, Colesevelam Intermediates Avatrombopag Intermediate Relugolix Intermediate Temozolomide Intermediates Elagolix Intermediate Nintedanid Intermediate Elobixibat Intermediate Rimegepant Intermediate Empagliflozin Intermediate Ubrogepant Intermediate Baricitinib Intermediate Ruxolitinib Intermediate |
|---|
Contact in Japan
| Japan Agent | Nanjing Confidence Chemical Co.,Ltd. |
|---|
Product introduction
Dehydroabietylamine，CAS 1446-61-3Ethyl 4-butylaminobenzoate, CAS 94-32-6(R)-(-)-Epichlorohydrin，CAS 51594-55-9(S)-(+)-Epichlorohydrin, CAS 67843-74-7Allylamine, CAS No.: 107-11-9Sevelamer, Colesevelam Intermediates Avatrombopag IntermediateRelugolix IntermediateTemozolomide IntermediatesElagolix IntermediateNintedanid Intermediate Elobixibat IntermediateRimegepant IntermediateEmpagliflozin IntermediateUbrogepant IntermediateBaricitinib IntermediateRuxolitinib Intermediate